Twin Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.48M | Sell |
52,874
-43,857
| -45% | -$1.17M | 0.19% | 120 |
|
|
2025
Q4 | $2.41M | Buy |
96,731
+5,726
| +6% | +$144K | 0.3% | 84 |
|
|
2025
Q3 | $2.32M | Sell |
91,005
-1,722
| -2% | -$42.5K | 0.29% | 90 |
|
|
2025
Q2 | $2.25M | Buy |
92,727
+26,118
| +39% | +$609K | 0.24% | 110 |
|
|
2025
Q1 | $1.69M | Sell |
66,609
-829
| -1% | -$21.7K | 0.2% | 129 |
|
|
2024
Q4 | $1.79M | Sell |
67,438
-446
| -0.7% | -$12.1K | 0.2% | 129 |
|
|
2024
Q3 | $1.96M | Buy |
67,884
+47,192
| +228% | +$1.38M | 0.22% | 125 |
|
|
2024
Q2 | $579K | Sell |
20,692
-200
| -1% | -$5.51K | 0.07% | 218 |
|
|
2024
Q1 | $580K | Sell |
20,892
-110,861
| -84% | -$3.08M | 0.07% | 218 |
|
|
2023
Q4 | $3.79M | Sell |
131,753
-3,591
| -3% | -$109K | 0.5% | 53 |
|
|
2023
Q3 | $4.49M | Buy |
135,344
+4,096
| +3% | +$145K | 0.64% | 31 |
|
|
2023
Q2 | $4.81M | Buy |
131,248
+12,551
| +11% | +$489K | 0.63% | 31 |
|
|
2023
Q1 | $4.84M | Sell |
118,697
-42,994
| -27% | -$1.86M | 0.66% | 28 |
|
|
2022
Q4 | $8.29M | Sell |
161,691
-2,376
| -1% | -$114K | 1.07% | 14 |
|
|
2022
Q3 | $7.18M | Sell |
164,067
-565
| -0.3% | -$27.5K | 0.97% | 17 |
|
|
2022
Q2 | $8.63M | Sell |
164,632
-1,971
| -1% | -$100K | 1.1% | 13 |
|
|
2022
Q1 | $8.63M | Sell |
166,603
-15,055
| -8% | -$781K | 0.93% | 17 |
|
|
2021
Q4 | $10.7M | Buy |
181,658
+12,985
| +8% | +$643K | 1.07% | 14 |
|
|
2021
Q3 | $7.25M | Sell |
168,673
-4,920
| -3% | -$218K | 0.74% | 23 |
|
|
2021
Q2 | $6.8M | Buy |
173,593
+10,440
| +6% | +$406K | 0.63% | 36 |
|
|
2021
Q1 | $5.91M | Sell |
163,153
-12,920
| -7% | -$459K | 0.59% | 42 |
|
|
2020
Q4 | $6.48M | Sell |
176,073
-16,619
| -9% | -$610K | 0.59% | 43 |
|
|
2020
Q3 | $6.71M | Buy |
192,692
+1,159
| +0.6% | +$40.6K | 0.61% | 42 |
|
|
2020
Q2 | $5.94M | Sell |
191,533
-52,248
| -21% | -$1.78M | 0.57% | 45 |
|
|
2020
Q1 | $7.55M | Sell |
243,781
-2,118
| -0.9% | -$72.2K | 0.82% | 28 |
|
|
2019
Q4 | $9.14M | Sell |
245,899
-18,561
| -7% | -$661K | 0.77% | 30 |
|
|
2019
Q3 | $9.02M | Sell |
264,460
-9,886
| -4% | -$359K | 0.65% | 38 |
|
|
2019
Q2 | $11.3M | Sell |
274,346
-104,441
| -28% | -$4.15M | 0.78% | 33 |
|
|
2019
Q1 | $15.3M | Sell |
378,787
-246,045
| -39% | -$9.85M | 0.75% | 33 |
|
|
2018
Q4 | $25.9M | Sell |
624,832
-27,043
| -4% | -$1.12M | 1.46% | 11 |
|
|
2018
Q3 | $27.3M | Buy |
651,875
+40,081
| +7% | +$1.54M | 1.25% | 10 |
|
|
2018
Q2 | $21.1M | Buy |
611,794
+6,155
| +1% | +$210K | 1.06% | 15 |
|
|
2018
Q1 | $20.4M | Sell |
605,639
-27,414
| -4% | -$942K | 1.05% | 15 |
|
|
2017
Q4 | $21.8M | Buy |
633,053
+49,390
| +8% | +$1.68M | 1.07% | 16 |
|
|
2017
Q3 | $19.8M | Buy |
583,663
+45,596
| +8% | +$1.47M | 1.04% | 15 |
|
|
2017
Q2 | $17.1M | Buy |
538,067
+42,908
| +9% | +$1.35M | 1.01% | 17 |
|
|
2017
Q1 | $16.1M | Buy |
495,159
+32,021
| +7% | +$1.01M | 1% | 18 |
|
|
2016
Q4 | $14.3M | Sell |
463,138
-13,850
| -3% | -$423K | 0.92% | 23 |
|
|
2016
Q3 | $15.3M | Buy |
476,988
+73,791
| +18% | +$2.47M | 1.03% | 17 |
|
|
2016
Q2 | $13.5M | Sell |
403,197
-6,588
| -2% | -$210K | 1.01% | 17 |
|
|
2016
Q1 | $11.5M | Buy |
409,785
+13,871
| +4% | +$396K | 0.89% | 26 |
|
|
2015
Q4 | $12.1M | Buy |
395,914
+31,694
| +9% | +$997K | 0.99% | 23 |
|
|
2015
Q3 | $10.9M | Buy |
364,220
+98,243
| +37% | +$3.15M | 1.03% | 21 |
|
|
2015
Q2 | $8.46M | Buy |
265,977
+66,550
| +33% | +$2.17M | 0.76% | 34 |
|
|
2015
Q1 | $6.58M | Sell |
199,427
-1,486
| -0.7% | -$47.2K | 0.58% | 48 |
|
|
2014
Q4 | $5.94M | Sell |
200,913
-82,413
| -29% | -$2.36M | 0.57% | 49 |
|
|
2014
Q3 | $7.95M | Sell |
283,326
-26,318
| -8% | -$739K | 0.81% | 26 |
|
|
2014
Q2 | $8.72M | Sell |
309,644
-11,057
| -3% | -$315K | 0.88% | 22 |
|
|
2014
Q1 | $9.77M | Sell |
320,701
-6,977
| -2% | -$208K | 1.03% | 16 |
|
|
2013
Q4 | $9.52M | Sell |
327,678
-14,809
| -4% | -$431K | 1.02% | 16 |
|
|
2013
Q3 | $9.33M | Sell |
342,487
-14,334
| -4% | -$390K | 1% | 17 |
|
|
2013
Q2 | $9.48M | Buy |
+356,821
| New | +$9.86M | 1.01% | 18 |
|
Other funds holding PFE
VCM
VPM
Twin Capital Management's PFE Position: Q1 2026 in Review
Twin Capital Management reduced its Pfizer (PFE) stake by 45% in Q1 2026, selling an estimated $1.17M and leaving 52,874 shares worth $1.48M. The position accounts for 0.19% of the portfolio, ranked #120.
Twin Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $27.3M in Q3 2018. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Twin Capital Management held 52,874 shares of Pfizer worth $1.48M as of Q1 2026.
- Twin Capital Management sold 43,857 Pfizer shares in Q1 2026, an estimated $1.17M.
- Pfizer made up 0.19% of Twin Capital Management's portfolio in Q1 2026, its #120 holding.
- Twin Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Twin Capital Management's Pfizer position peaked at $27.3M in Q3 2018.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Twin Capital Management's 13F filing for Q1 2026, filed 5 May 2026.